IL6 and breast carcinoma: A recent study revealed that activation or increases in multiple pathways, such as the TGF-β signaling pathway, the inflammatory response, the IL6-JAK-STAT3 and TNF-γ–NF–kB signaling, and the IFN-γ response, have been connected to the onset or progression of breast cancer.199